Cellectis S.A.
CLLS
$1.53
$0.021.33%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 5.92M | -23.06M | -25.27M | 5.64M | -41.80M |
| Total Depreciation and Amortization | 5.07M | 4.72M | 4.73M | 4.57M | 5.11M |
| Total Amortization of Deferred Charges | 758.00K | -- | -- | -- | 69.00K |
| Total Other Non-Cash Items | -17.06M | 16.22M | 11.72M | -24.64M | 17.29M |
| Change in Net Operating Assets | 5.26M | -3.71M | 61.01M | -8.89M | 59.04M |
| Cash from Operations | -47.00K | -5.83M | 52.18M | -23.32M | 39.72M |
| Capital Expenditure | -550.00K | -777.00K | -1.04M | -218.00K | -276.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -16.11M | 23.11M | -105.39M | -1.83M | -13.38M |
| Cash from Investing | -16.66M | 22.33M | -106.43M | -2.05M | -13.65M |
| Total Debt Issued | 6.88M | 110.00K | -44.00K | 16.25M | 1.39M |
| Total Debt Repaid | -3.74M | -4.09M | -4.11M | -4.13M | -4.03M |
| Issuance of Common Stock | 206.00K | -- | 83.03M | -- | 46.37M |
| Repurchase of Common Stock | -- | -207.00K | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -423.00K | -36.00K | -369.00K | -226.00K | -2.15M |
| Cash from Financing | 2.93M | -4.22M | 78.51M | 11.90M | 41.58M |
| Foreign Exchange rate Adjustments | -2.06M | -2.24M | 1.81M | -267.00K | 1.71M |
| Miscellaneous Cash Flow Adjustments | 1.00K | -1.00K | 1.00K | -- | -1.00K |
| Net Change in Cash | -15.84M | 10.05M | 26.07M | -13.74M | 69.35M |